Cite
HARVARD Citation
Le Bourgeois, A. et al. (n.d.). REDUCED INTENSITY (FB2) VS REDUCED TOXICITY MYELOABLATIVE (FB3‐4) FLUDARABINE/BUSULFAN‐BASED CONDITIONING REGIMENS FOR NON‐HODGKIN LYMPHOMA (NHL) ALLOGRAFTED PATIENTS. Hematological oncology. pp. 193-194. [Online].